A question of ethics: Medical journals are an immoral marketing tool for drug companies, according to a former editor of the BMJ.
Sarah Boseley
The Guardian
June 30, 2005
(courtsey of Clare Leibfarth)


Richard Smith, former editor of BMJ has strong words for the medical journals, the publishing community and drug companies. He questions the validity of published research, believes medical journals are "little more than a marketing tool of the drug companies," and they are immoral in charging for access to scientific literature.